aluates Reports

$ 0.0

Automative

Global NASH Therapeutic Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-13O13699

Global NASH Therapeutic Drugs Market Research Report 2023

BUY CHAPTERS

Global NASH Therapeutic Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-13O13699

Report

December 2024

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Galmed Pharmaceuticals

Genfit SA

Gilead Sciences Inc

Intercept Pharmaceuticals Inc

Zydus Cadila

Allergan Plc (Tobira)

NASH Therapeutic Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

NASH Therapeutic Drugs Market

Market Analysis and Insights: Global NASH Therapeutic Drugs Market

The global NASH Therapeutic Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for NASH Therapeutic Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of NASH Therapeutic Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for NASH Therapeutic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the NASH Therapeutic Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global NASH Therapeutic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for NASH Therapeutic Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of NASH Therapeutic Drugs Market Report

Report Metric	Details
Report Name	NASH Therapeutic Drugs Market
CAGR	5%
Segment by Type	Vitamin E and Pioglitazone Ocaliva Elafibranor Selonsertib and Cenicriviroc
Segment by Application	Hospital Pharmacy Online Provider Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan Plc (Tobira), Bristol Myers Squibb, Galmed Pharmaceuticals, Genfit SA, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Zydus Cadila
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of NASH Therapeutic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NASH Therapeutic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NASH Therapeutic Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the NASH Therapeutic Drugs Market report?

Ans: The main players in the NASH Therapeutic Drugs Market are Allergan Plc (Tobira), Bristol Myers Squibb, Galmed Pharmaceuticals, Genfit SA, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Zydus Cadila

What are the Application segmentation covered in the NASH Therapeutic Drugs Market report?

Ans: The Applications covered in the NASH Therapeutic Drugs Market report are Hospital Pharmacy, Online Provider, Retail Pharmacy

What are the Type segmentation covered in the NASH Therapeutic Drugs Market report?

Ans: The Types covered in the NASH Therapeutic Drugs Market report are Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Vitamin E and Pioglitazone

1.2.3 Ocaliva

1.2.4 Elafibranor

1.2.5 Selonsertib and Cenicriviroc

1.3 Market by Application

1.3.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacy

1.3.3 Online Provider

1.3.4 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global NASH Therapeutic Drugs Market Perspective (2019-2030)

2.2 Global NASH Therapeutic Drugs Growth Trends by Region

2.2.1 NASH Therapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 NASH Therapeutic Drugs Historic Market Size by Region (2019-2024)

2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Region (2025-2030)

2.3 NASH Therapeutic Drugs Market Dynamics

2.3.1 NASH Therapeutic Drugs Industry Trends

2.3.2 NASH Therapeutic Drugs Market Drivers

2.3.3 NASH Therapeutic Drugs Market Challenges

2.3.4 NASH Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue NASH Therapeutic Drugs by Players

3.1.1 Global NASH Therapeutic Drugs Revenue by Players (2019-2024)

3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2019-2024)

3.2 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of NASH Therapeutic Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global NASH Therapeutic Drugs Market Concentration Ratio

3.4.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2023

3.5 Global Key Players of NASH Therapeutic Drugs Head office and Area Served

3.6 Global Key Players of NASH Therapeutic Drugs, Product and Application

3.7 Global Key Players of NASH Therapeutic Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 NASH Therapeutic Drugs Breakdown Data by Type

4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2019-2024)

4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2025-2030)

5 NASH Therapeutic Drugs Breakdown Data by Application

5.1 Global NASH Therapeutic Drugs Historic Market Size by Application (2019-2024)

5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America NASH Therapeutic Drugs Market Size (2019-2030)

6.2 North America NASH Therapeutic Drugs Market Size by Type

6.2.1 North America NASH Therapeutic Drugs Market Size by Type (2019-2024)

6.2.2 North America NASH Therapeutic Drugs Market Size by Type (2025-2030)

6.2.3 North America NASH Therapeutic Drugs Market Share by Type (2019-2030)

6.3 North America NASH Therapeutic Drugs Market Size by Application

6.3.1 North America NASH Therapeutic Drugs Market Size by Application (2019-2024)

6.3.2 North America NASH Therapeutic Drugs Market Size by Application (2025-2030)

6.3.3 North America NASH Therapeutic Drugs Market Share by Application (2019-2030)

6.4 North America NASH Therapeutic Drugs Market Size by Country

6.4.1 North America NASH Therapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America NASH Therapeutic Drugs Market Size by Country (2019-2024)

6.4.3 North America NASH Therapeutic Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe NASH Therapeutic Drugs Market Size (2019-2030)

7.2 Europe NASH Therapeutic Drugs Market Size by Type

7.2.1 Europe NASH Therapeutic Drugs Market Size by Type (2019-2024)

7.2.2 Europe NASH Therapeutic Drugs Market Size by Type (2025-2030)

7.2.3 Europe NASH Therapeutic Drugs Market Share by Type (2019-2030)

7.3 Europe NASH Therapeutic Drugs Market Size by Application

7.3.1 Europe NASH Therapeutic Drugs Market Size by Application (2019-2024)

7.3.2 Europe NASH Therapeutic Drugs Market Size by Application (2025-2030)

7.3.3 Europe NASH Therapeutic Drugs Market Share by Application (2019-2030)

7.4 Europe NASH Therapeutic Drugs Market Size by Country

7.4.1 Europe NASH Therapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe NASH Therapeutic Drugs Market Size by Country (2019-2024)

7.4.3 Europe NASH Therapeutic Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China NASH Therapeutic Drugs Market Size (2019-2030)

8.2 China NASH Therapeutic Drugs Market Size by Type

8.2.1 China NASH Therapeutic Drugs Market Size by Type (2019-2024)

8.2.2 China NASH Therapeutic Drugs Market Size by Type (2025-2030)

8.2.3 China NASH Therapeutic Drugs Market Share by Type (2019-2030)

8.3 China NASH Therapeutic Drugs Market Size by Application

8.3.1 China NASH Therapeutic Drugs Market Size by Application (2019-2024)

8.3.2 China NASH Therapeutic Drugs Market Size by Application (2025-2030)

8.3.3 China NASH Therapeutic Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia NASH Therapeutic Drugs Market Size (2019-2030)

9.2 Asia NASH Therapeutic Drugs Market Size by Type

9.2.1 Asia NASH Therapeutic Drugs Market Size by Type (2019-2024)

9.2.2 Asia NASH Therapeutic Drugs Market Size by Type (2025-2030)

9.2.3 Asia NASH Therapeutic Drugs Market Share by Type (2019-2030)

9.3 Asia NASH Therapeutic Drugs Market Size by Application

9.3.1 Asia NASH Therapeutic Drugs Market Size by Application (2019-2024)

9.3.2 Asia NASH Therapeutic Drugs Market Size by Application (2025-2030)

9.3.3 Asia NASH Therapeutic Drugs Market Share by Application (2019-2030)

9.4 Asia NASH Therapeutic Drugs Market Size by Region

9.4.1 Asia NASH Therapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia NASH Therapeutic Drugs Market Size by Region (2019-2024)

9.4.3 Asia NASH Therapeutic Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Allergan Plc (Tobira)

11.1.1 Allergan Plc (Tobira) Company Details

11.1.2 Allergan Plc (Tobira) Business Overview

11.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction

11.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.1.5 Allergan Plc (Tobira) Recent Developments

11.2 Bristol Myers Squibb

11.2.1 Bristol Myers Squibb Company Details

11.2.2 Bristol Myers Squibb Business Overview

11.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction

11.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.2.5 Bristol Myers Squibb Recent Developments

11.3 Galmed Pharmaceuticals

11.3.1 Galmed Pharmaceuticals Company Details

11.3.2 Galmed Pharmaceuticals Business Overview

11.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction

11.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.3.5 Galmed Pharmaceuticals Recent Developments

11.4 Genfit SA

11.4.1 Genfit SA Company Details

11.4.2 Genfit SA Business Overview

11.4.3 Genfit SA NASH Therapeutic Drugs Introduction

11.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.4.5 Genfit SA Recent Developments

11.5 Gilead Sciences, Inc.

11.5.1 Gilead Sciences, Inc. Company Details

11.5.2 Gilead Sciences, Inc. Business Overview

11.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction

11.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.5.5 Gilead Sciences, Inc. Recent Developments

11.6 Intercept Pharmaceuticals, Inc.

11.6.1 Intercept Pharmaceuticals, Inc. Company Details

11.6.2 Intercept Pharmaceuticals, Inc. Business Overview

11.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction

11.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.6.5 Intercept Pharmaceuticals, Inc. Recent Developments

11.7 Zydus Cadila

11.7.1 Zydus Cadila Company Details

11.7.2 Zydus Cadila Business Overview

11.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction

11.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.7.5 Zydus Cadila Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bristol–Myers Squibb

Galmed Pharmaceuticals

Genfit SA

Gilead Sciences Inc

Intercept Pharmaceuticals Inc

Zydus Cadila

Allergan Plc (Tobira)

List of Tables

Table 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Vitamin E and Pioglitazone

Table 3. Key Players of Ocaliva

Table 4. Key Players of Elafibranor

Table 5. Key Players of Selonsertib and Cenicriviroc

Table 6. Global NASH Therapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global NASH Therapeutic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global NASH Therapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global NASH Therapeutic Drugs Market Share by Region (2019-2024)

Table 10. Global NASH Therapeutic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global NASH Therapeutic Drugs Market Share by Region (2025-2030)

Table 12. NASH Therapeutic Drugs Market Trends

Table 13. NASH Therapeutic Drugs Market Drivers

Table 14. NASH Therapeutic Drugs Market Challenges

Table 15. NASH Therapeutic Drugs Market Restraints

Table 16. Global NASH Therapeutic Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global NASH Therapeutic Drugs Revenue Share by Players (2019-2024)

Table 18. Global Top NASH Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2023)

Table 19. Global NASH Therapeutic Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by NASH Therapeutic Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of NASH Therapeutic Drugs, Headquarters and Area Served

Table 22. Global Key Players of NASH Therapeutic Drugs, Product and Application

Table 23. Global Key Players of NASH Therapeutic Drugs, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global NASH Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global NASH Therapeutic Drugs Revenue Market Share by Type (2019-2024)

Table 27. Global NASH Therapeutic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global NASH Therapeutic Drugs Revenue Market Share by Type (2025-2030)

Table 29. Global NASH Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global NASH Therapeutic Drugs Revenue Share by Application (2019-2024)

Table 31. Global NASH Therapeutic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global NASH Therapeutic Drugs Revenue Share by Application (2025-2030)

Table 33. North America NASH Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America NASH Therapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America NASH Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America NASH Therapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America NASH Therapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America NASH Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America NASH Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe NASH Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe NASH Therapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe NASH Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe NASH Therapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe NASH Therapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe NASH Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe NASH Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. China NASH Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 48. China NASH Therapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 49. China NASH Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 50. China NASH Therapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia NASH Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia NASH Therapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia NASH Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia NASH Therapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia NASH Therapeutic Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia NASH Therapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia NASH Therapeutic Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America NASH Therapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 65. Allergan Plc (Tobira) Company Details

Table 66. Allergan Plc (Tobira) Business Overview

Table 67. Allergan Plc (Tobira) NASH Therapeutic Drugs Product

Table 68. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 69. Allergan Plc (Tobira) Recent Developments

Table 70. Bristol Myers Squibb Company Details

Table 71. Bristol Myers Squibb Business Overview

Table 72. Bristol Myers Squibb NASH Therapeutic Drugs Product

Table 73. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 74. Bristol Myers Squibb Recent Developments

Table 75. Galmed Pharmaceuticals Company Details

Table 76. Galmed Pharmaceuticals Business Overview

Table 77. Galmed Pharmaceuticals NASH Therapeutic Drugs Product

Table 78. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 79. Galmed Pharmaceuticals Recent Developments

Table 80. Genfit SA Company Details

Table 81. Genfit SA Business Overview

Table 82. Genfit SA NASH Therapeutic Drugs Product

Table 83. Genfit SA Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 84. Genfit SA Recent Developments

Table 85. Gilead Sciences, Inc. Company Details

Table 86. Gilead Sciences, Inc. Business Overview

Table 87. Gilead Sciences, Inc. NASH Therapeutic Drugs Product

Table 88. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 89. Gilead Sciences, Inc. Recent Developments

Table 90. Intercept Pharmaceuticals, Inc. Company Details

Table 91. Intercept Pharmaceuticals, Inc. Business Overview

Table 92. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product

Table 93. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 94. Intercept Pharmaceuticals, Inc. Recent Developments

Table 95. Zydus Cadila Company Details

Table 96. Zydus Cadila Business Overview

Table 97. Zydus Cadila NASH Therapeutic Drugs Product

Table 98. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 99. Zydus Cadila Recent Developments

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global NASH Therapeutic Drugs Market Share by Type: 2023 VS 2030

Figure 3. Vitamin E and Pioglitazone Features

Figure 4. Ocaliva Features

Figure 5. Elafibranor Features

Figure 6. Selonsertib and Cenicriviroc Features

Figure 7. Global NASH Therapeutic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global NASH Therapeutic Drugs Market Share by Application: 2023 VS 2030

Figure 9. Hospital Pharmacy Case Studies

Figure 10. Online Provider Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. NASH Therapeutic Drugs Report Years Considered

Figure 13. Global NASH Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global NASH Therapeutic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global NASH Therapeutic Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global NASH Therapeutic Drugs Market Share by Players in 2023

Figure 17. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2023

Figure 19. North America NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America NASH Therapeutic Drugs Market Share by Type (2019-2030)

Figure 21. North America NASH Therapeutic Drugs Market Share by Application (2019-2030)

Figure 22. North America NASH Therapeutic Drugs Market Share by Country (2019-2030)

Figure 23. United States NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe NASH Therapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe NASH Therapeutic Drugs Market Share by Type (2019-2030)

Figure 27. Europe NASH Therapeutic Drugs Market Share by Application (2019-2030)

Figure 28. Europe NASH Therapeutic Drugs Market Share by Country (2019-2030)

Figure 29. Germany NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China NASH Therapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China NASH Therapeutic Drugs Market Share by Type (2019-2030)

Figure 37. China NASH Therapeutic Drugs Market Share by Application (2019-2030)

Figure 38. Asia NASH Therapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia NASH Therapeutic Drugs Market Share by Type (2019-2030)

Figure 40. Asia NASH Therapeutic Drugs Market Share by Application (2019-2030)

Figure 41. Asia NASH Therapeutic Drugs Market Share by Region (2019-2030)

Figure 42. Japan NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America NASH Therapeutic Drugs Market Share by Country (2019-2030)

Figure 52. Brazil NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 59. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 60. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 61. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 62. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 63. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 64. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions